Rocket Lab Just Had the Worst Week in Its History. Here's What I'd Do With the Stock Now.
Rocket Lab's stock fell 23% in a week, its worst decline since its IPO, due to Neutron rocket delays and regulatory challenges to its Iridium acquisition. The company generates 19% of revenue from launch services, with 81% from space systems. Its backlog is $2.36B, exceeding 2026 revenue projections. Analysts expect 38% and 31% revenue growth in 2027 and 2028, respectively, contingent on Neutron's success and Iridium's acquisition.
How this was made
The 30-second read
Why it matters
The combined launch delay and FCC challenge create near‑term downside risk for both Rocket Lab and Iridium, while the broader space launch market may see heightened scrutiny of smaller players.
Market read
The article signals short‑term pressure on RKLB and IRDM due to execution and regulatory risks, with limited broader market impact.
What to watch
Potential upside from the growing demand for satellite constellations and the $2.36 billion backlog that may offset short‑term setbacks.
Background
The piece is an opinion‑style recap of Rocket Lab's recent week of setbacks, focusing on launch delays and regulatory challenges to its Iridium acquisition.
Ticker impact
Rocket Lab's stock fell 23% after announcing a delay of the Neutron launch to 2027 and a pending FCC challenge to its Iridium acquisition.
likely further downside as investors price in execution risk.
The article highlights concrete setbacks (launch delay, FCC challenge) that directly affect the company's near‑term outlook.
Iridium is the target of Rocket Lab's $8 billion acquisition, which faces a potential FCC challenge raised by Ligado Networks.
potential pressure if the deal stalls or is blocked.
Regulatory scrutiny could delay or derail the transaction, affecting Iridium's share outlook.
Market effects
Highlights execution risk for small‑satellite launch providers and may dampen enthusiasm for the broader commercial space sector.
U.S. space‑technology investors may see short‑term pullback.
Limited to investors tracking commercial launch companies; no broad macro impact.
Counterpoint
If Rocket Lab can resolve the Neutron delay and secure FCC approval, the stock could rebound sharply from the oversold level.
Key entities
- companyRocket Lab
U.S. listed launch services provider (NASDAQ: RKLB).
- companyIridium
Satellite communications operator (NASDAQ: IRDM) targeted for acquisition.
- companyLigado Networks
Filed FCC objection to Rocket Lab's Iridium takeover.
